It has also been shown to reduce the production of angiogenic factors, such as VEGF, by macrophages and cancer cells while also downregulating the rapidly accelerated fibrosarcoma (RAF)–mitogen‐activated protein kinase (MAPK) pathway, inhibiting angiogenesis.49 The gene discussed is VEGFA; the disease is cancer.